Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for NEVIF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
November 30, 2025 0.00
August 31, 2025 0.00
May 31, 2025 0.00
February 28, 2025 0.00
November 30, 2024 0.0514M
August 31, 2024 0.0126M
May 31, 2024 -0.0551M
February 29, 2024 -0.0179M
November 30, 2023 -0.0107M
August 31, 2023 -0.7054M
May 31, 2023 0.00
February 28, 2023 0.0054M
November 30, 2022 0.0062M
August 31, 2022 0.0005M
May 31, 2022 0.00
February 28, 2022 0.00
November 30, 2021 0.00
August 31, 2021 0.00
Date Value
May 31, 2021 0.00
February 28, 2021 0.00
November 30, 2020 0.00
August 31, 2020 0.00
May 31, 2020 0.00
February 29, 2020 0.00
November 30, 2019 0.00
August 31, 2019 0.00
May 31, 2019 -0.0001M
February 28, 2019 -0.0016M
November 30, 2018 -0.0001M
August 31, 2018 -0.0049M
May 31, 2018 0.00
February 28, 2018 0.00
November 30, 2017 -0.0061M
August 31, 2017 -0.0151M
May 31, 2017 -0.0257M
February 28, 2017 0.00

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Medifast, Inc. -1.233M
Integrated BioPharma, Inc. 0.006M
BioForce Nanosciences Holdings, Inc. 0.00
Skinvisible, Inc. 0.00
Skinhealth Systems, Inc. -1.205M

Cash from Investing (Quarterly) Related Metrics